Tag: biotechnology
-
Corn, Shellfish Ingredients Enable DNA Vaccine Pills
Biomaterials researchers discovered substances from corn and shellfish can package genetic material to pass through the digestive system, making possible vaccines as pills rather than injections.
-
Engineered Bacteria Designed to Detect Gut Inflammation
A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut.
-
Antibody Shows Promise Against Marburg Virus Infections
Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections.
-
Enhanced Gene Therapy Boosts Anti-Tumor Response
Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors.
-
Zika DNA Vaccine Begins Clinical Trial
A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease.
-
Start-Up Licensing Flexible Genome-Editing Technology
A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression.
-
CARB-X Commits $48M for Antibiotic Resistance R&D
A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately.
-
FDA Approves Multiple Sclerosis Therapy
The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease.
-
Climate-Resistant Oilseed Crop Plant Developed
An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate.
-
Univ. of California to Gain European Crispr-Cas9 Patent
A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques.